Susquehanna International Group
CGON icon

Susquehanna International Group’s CG Oncology CGON Stock Holding History

Susquehanna International Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.5M Buy
376,700
+133,900
+55% +$7.59M ﹤0.01% 1921
2025
Q4 		$10.1M Buy
242,800
+192,300
+381% +$7.96M ﹤0.01% 3027
2025
Q3 		$2.03M Sell
50,500
-1,000
-2% -$29.1K ﹤0.01% 5763
2025
Q2 		$1.34M Buy
51,500
+21,200
+70% +$511K ﹤0.01% 6709
2025
Q1 		$742K Sell
30,300
-133,100
-81% -$3.74M ﹤0.01% 8008
2024
Q4 		$4.69M Buy
163,400
+110,300
+208% +$3.77M ﹤0.01% 3695
2024
Q3 		$2M Buy
+53,100
New +$1.86M ﹤0.01% 5260

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group's CGON Position: Q1 2026 in Review

Susquehanna International Group opened a new position in CG Oncology (CGON) in Q1 2026: 25,803 shares worth $1.75M. The stake represents ﹤0.01% of the portfolio and ranks #6488 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in CGON as recently as Q2 2025.

Susquehanna International Group first reported a position in CGON in Q1 2024 and has held it in 6 quarters since. The position peaked at $2.44M in Q2 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Susquehanna International Group held 25,803 shares of CG Oncology worth $1.75M as of Q1 2026.
  • CG Oncology was a new Susquehanna International Group position in Q1 2026.
  • CG Oncology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6488 holding.
  • Susquehanna International Group first reported a position in CG Oncology in Q1 2024 and has held it in 6 quarters since.
  • Susquehanna International Group's CG Oncology position peaked at $2.44M in Q2 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.